Analysis of left ventricular mass in untreated men and in men treated with agalsidase-beta: data from the Fabry Registry
Dominique P Germain, Frank Weidemann, Ademola Abiose, Manesh R Patel, Marta Cizmarik, J Alexander Cole, Dana Beitner-Johnson, Karelle Benistan, Gustavo Cabrera, Joel Charrow, Ilkka Kantola, Ales Linhart, Kathy Nicholls, Markus Niemann, C Ronald Scott, Katherine Sims, Stephen Waldek, David G Warnock, Joerg Strotmann
Genetics in Medicine | NATURE PUBLISHING GROUP | Published : 2013
Genzyme Corporation sponsors the Fabry Registry. Members of the Fabry Registry Board of Advisors include D. P. G., F. W., A. A., M. R. P., G. C., J.C., A. L., M. R. P., C. R. S., K. S., S. W., and D. G. W. Authors who have received research funds or travel support from Genzyme include D. P. G., M. R. P., S. W., J.S., and D. G. W. Authors who have received speaking fees from Genzyme include D. P. G., S. W., and J.S. M. C., A. C., and D.B.J. are Genzyme employees. D. G. W. has served as a paid consultant to Genzyme and also has consultancies and has received travel funds from Abbot, Amgen, Amicus, Gilead, Parion, Relypsa, and Shire. The results presented in this article have not been published previously in whole or part, except in abstract format.